These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8702314)

  • 21. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
    Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of tumor angiogenesis as an independent prognostic factor in axillary node-negative breast cancer].
    Inada K; Toi M; Hoshina S; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():59-65. PubMed ID: 7538284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
    Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G;
    Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
    Kröger N; Milde-Langosch K; Riethdorf S; Schmoor C; Schumacher M; Zander AR; Löning T
    Clin Cancer Res; 2006 Jan; 12(1):159-68. PubMed ID: 16397038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement.
    Bebenek M; Bar JK; Harlozinska A; Sedlaczek P
    Anticancer Res; 1998; 18(1B):619-23. PubMed ID: 9568187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
    Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J
    Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
    Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins.
    Zhang GJ; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Jpn J Clin Oncol; 1997 Dec; 27(6):371-7. PubMed ID: 9437997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
    Chen SL; Hoehne FM; Giuliano AE
    Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
    Camp RL; Rimm EB; Rimm DL
    Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.